Capito backs sits at the center of this dementia and brain health question.

Senator Shelley Moore Capito is backing the AADAPT (Accelerating Access to Dementia & Alzheimer’s Provider Training) Act, a bipartisan bill that directly addresses one of the biggest gaps in American dementia care: most Alzheimer’s diagnoses are made by primary care providers who lack specialized training. Reintroduced in the Senate in March 2026 with support from Democrats and Republicans alike, the legislation expands virtual continuing education opportunities so that the physicians and nurse practitioners who patients first see can better recognize, diagnose, and manage Alzheimer’s disease and related dementias. This matters because 85% of initial Alzheimer’s diagnoses come from primary care settings—not specialists—yet these providers consistently report feeling unprepared for dementia care despite making the majority of diagnoses. The AADAPT Act works by amending the Public Health Service Act to expand the Project ECHO Grant Program, creating free, remote continuing education led by dementia experts.

For a primary care provider in rural Wyoming or a rural county in New Jersey, this removes a major barrier: no expensive travel to urban medical centers, no continuing education fees, and the ability to learn on your own schedule. The bill also has a companion measure in the U.S. House, signaling momentum for this approach. This article explores the specific training gap the legislation targets, who benefits, what the AADAPT Act actually does, and why this matters for the roughly 7 million Americans currently living with Alzheimer’s disease and another 3.5 million who remain undiagnosed.

What Is the AADAPT Act and Why Do Primary Care Doctors Need Better Dementia Training?
How Does Virtual Training Help Address Rural and Underserved Healthcare Gaps?
What Are the Current Statistics on Alzheimer’s Diagnosis and the Training Gap?
Who Benefits From the AADAPT Act and What Are the Real-World Implications?
What Barriers Might the AADAPT Act Not Overcome?
How Do the Bipartisan Sponsors Justify This Investment?
What Does Dementia Care Look Like If the AADAPT Act Passes?
Conclusion

What Is the AADAPT Act and Why Do Primary Care Doctors Need Better Dementia Training?

The AADAPT Act addresses a paradox: primary care physicians make about 85% of initial Alzheimer’s diagnoses, yet most receive little to no dementia-specific training during medical school or residency. A primary care doctor in Des Moines might be the first—and sometimes only—physician to evaluate a patient showing signs of cognitive decline, yet they’re expected to distinguish normal aging from early dementia, understand different types of dementia, recognize non-Alzheimer’s pathology, and coordinate referrals to neurology or geriatrics. Without specialized training, misdiagnosis or delayed diagnosis is common. Some primary care providers mistake early Alzheimer’s for depression or normal forgetfulness; others miss it entirely.

The legislation expands the existing Project ECHO model, which uses real-time videoconferencing and case-based learning to connect specialists with primary care providers. Under the AADAPT Act, these ECHO programs would be federally funded and specifically designed to teach dementia detection, diagnosis, and initial management. A primary care provider in Alaska could join a weekly virtual session led by a dementia specialist at a major academic center, present their own patient cases, and get immediate feedback. Over time, this builds diagnostic confidence and reduces the 50% of Alzheimer’s cases that currently go undiagnosed.

What Is the AADAPT Act and Why Do Primary Care Doctors Need Better Dementia Training?

How Does Virtual Training Help Address Rural and Underserved Healthcare Gaps?

Rural and medically underserved communities face a particular disadvantage: specialists are concentrated in urban areas, and traveling for continuing education is costly and time-consuming. A provider in rural West Virginia—Capito’s home state—might have no neurologist or geriatrician within 100 miles. Virtual education via ECHO eliminates the geography problem. Providers attend from their clinic, often during lunch or after hours, and get real-time teaching without closing their practice or paying travel costs.

However, virtual training has a real limitation: it requires reliable broadband and protected video conferencing infrastructure. Rural clinics with poor internet connectivity or no private space for confidential clinical discussions may struggle to participate fully. The AADAPT Act would need to be paired with infrastructure improvements in those communities for maximum impact. Additionally, no virtual program replaces hands-on clinical experience with a specialist, so the legislation is best viewed as a tool to boost competency in primary care settings, not as a substitute for neurology referrals when those are needed.

What Are the Current Statistics on Alzheimer’s Diagnosis and the Training Gap?

Approximately 7 million Americans are currently living with Alzheimer’s disease, but only about 50% have received a diagnosis. That means roughly 3.5 million people with Alzheimer’s are undiagnosed, often because they or their families attribute memory problems to normal aging or because their primary care provider lacks the framework to recognize early-stage disease. Among those who are diagnosed, 85% received their initial diagnosis in a primary care setting—a family medicine clinic, an internist’s office, or a nurse practitioner-led urgent care. These settings are where most Americans first raise concerns about memory changes.

Yet primary care providers consistently report feeling unprepared for dementia evaluation. In surveys, many cite lack of training in cognitive assessment tools, uncertainty about when to refer to specialists, and gaps in knowledge about dementia subtypes and treatment options. The AADAPT Act directly targets this gap by funding Project ECHO programs that teach practical skills: how to administer a brief cognitive screening in 5 minutes during a routine visit, how to communicate a difficult diagnosis to a patient and family, how to monitor progression, and when referrals are appropriate. For example, a provider might learn to distinguish Alzheimer’s disease from vascular dementia based on imaging and clinical presentation, knowledge that currently requires specialized training.

What Are the Current Statistics on Alzheimer's Diagnosis and the Training Gap?

Who Benefits From the AADAPT Act and What Are the Real-World Implications?

Primary care providers themselves benefit most directly—physicians, nurse practitioners, physician assistants, and geriatric care managers who see dementia patients daily. But the downstream benefit flows to patients. A primary care provider who completes ECHO training is more likely to catch cognitive impairment early, when treatment options are broader and family planning (legal documents, care planning) is more feasible. For the family member whose mother has been dismissed as “just forgetful” at her annual physical, earlier diagnosis means earlier access to medications like aducanumab or lecanemab that slow cognitive decline—though these are most effective in early stages.

The tradeoff is one of resources and scale. The bill requires federal funding to support ECHO programs, and rollout will take time. Early participants will likely be clinics in health systems with existing relationships to academic dementia centers. Rural clinics, especially those in states with fewer academic medical centers, may face delays in accessing these programs. Capito’s bipartisan coalition (including Senators Klobuchar, Moran, Booker, Sullivan, Kim, Lankford, and Cantwell) reflects recognition that this is a national problem requiring federal investment, not something individual states or health systems should bear alone.

What Barriers Might the AADAPT Act Not Overcome?

Even with better training, primary care providers face structural barriers. Time is a critical constraint—a 15-minute office visit doesn’t leave space for a lengthy cognitive evaluation, even with a screening tool. Reimbursement is another: most insurance plans don’t pay differently for dementia screening, so there’s limited financial incentive for a busy clinic to invest staff time. The AADAPT Act improves knowledge but doesn’t change the underlying economics of primary care.

Additionally, cognitive impairment is often accompanied by other conditions—depression, thyroid disease, medication side effects—that mimic dementia. A primary care provider trained through ECHO might recognize memory loss but still struggle to determine its cause without imaging or specialized blood tests. In some cases, those tests aren’t available quickly enough or are too expensive for the patient. The legislation is most effective when paired with improved access to neuroimaging and diagnostic testing, which it doesn’t directly address.

What Barriers Might the AADAPT Act Not Overcome?

How Do the Bipartisan Sponsors Justify This Investment?

The bipartisan coalition backing the AADAPT Act—with sponsors from both conservative and progressive states—frames this as essential healthcare infrastructure. Capito, a Republican from West Virginia, joins Democrat Amy Klobuchar (Minnesota) and others in recognizing that Alzheimer’s crosses political lines. It affects families in coal-producing West Virginia as much as urban Minnesota. The bill also emphasizes workforce development: the U.S.

faces a shortage of geriatricians and dementia specialists, so improving primary care capacity is a practical alternative to waiting for enough specialists to be trained. For example, the Alzheimer’s Association and related organizations have identified the dementia care workforce as a critical bottleneck. Training 500 primary care providers through ECHO programs is more feasible and faster than training 500 new neurologists, which takes over a decade per person. This pragmatic logic—invest in existing primary care to close the gap faster—resonates across the political spectrum.

What Does Dementia Care Look Like If the AADAPT Act Passes?

If enacted, the legislation would likely lead to earlier diagnosis rates and more consistent dementia care at the primary care level. Over time, the 50% undiagnosed rate could decline. Patients in rural areas would have better access to dementia expertise without relocating or traveling long distances.

The legislation also sets a model: if ECHO works for dementia, it could be expanded to other conditions where primary care providers lack specialized training. Looking forward, the real success of the AADAPT Act depends on whether funding levels match the scale of the problem and whether programs reach the most underserved areas. The bill is a necessary but not sufficient step—it must be paired with broader reforms in primary care reimbursement, access to imaging and testing, and specialist referral networks. Still, it represents concrete progress on a problem that has been identified as urgent for over a decade.

Conclusion

Senator Shelley Moore Capito’s backing of the AADAPT Act reflects a growing recognition that Alzheimer’s detection and early care begins in primary care offices, not specialist clinics. By expanding federal funding for virtual dementia training through the Project ECHO model, the legislation removes geographic and cost barriers that have kept many primary care providers from gaining specialized knowledge.

With 85% of initial Alzheimer’s diagnoses made in primary care settings and 50% of cases remaining undiagnosed, better primary care training is overdue. The path forward requires not just passage of the AADAPT Act, but also sustained federal commitment to dementia workforce development, improved access to diagnostic tools, and reimbursement models that reward early detection. For families navigating dementia, and for the primary care providers trying to serve them, this bipartisan legislation offers a practical first step toward catching Alzheimer’s earlier and ensuring that expertise isn’t limited to major medical centers.